In a study published today (Sept. 11), researchers at the University of Wisconsin–Madison report the first full measurement of the proteins made by both types of stem cells. In a study that looked at four embryonic stem cells and four IPS cells, the proteins turned out to be 99 percent similar, says Joshua Coon, an associate professor of chemistry and biomolecular chemistry who directed the project.
Author: Morgridge Institute for Research
Chinese high schoolers to learn from stem cells
Eighteen students participating in the inaugural Global Wisconsin Idea Program — a unique pairing of American and Chinese teenagers — will join a Chinese university dean this week to learn more about the science of stem cells during a hands-on workshop hosted by the Morgridge Institute for Research.
Study shows patient’s own cells may hold therapeutic promise after reprogramming, gene correction
Scientists from the Morgridge Institute for Research, the University of Wisconsin–Madison, the University of California and the WiCell Research Institute moved gene therapy one step closer to clinical reality by determining that the process of correcting a genetic defect does not substantially increase the number of potentially cancer-causing mutations in induced pluripotent stem cells.
Morgridge Institute for Research announces scientific leadership team, research areas
The Morgridge Institute for Research, the private side of the new interdisciplinary Wisconsin Institutes for Discovery at the University of Wisconsin–Madison, has finalized its inaugural team of top scientists selected to bring to life the institute’s mission of accelerating discovery to delivery to improve human health.
Wisconsin, Morgridge scientists excise vector, exotic genes from induced stem cells
A team of scientists from the Morgridge Institute for Research at the University of Wisconsin–Madison reports that it has created induced human pluripotent stem (iPS) cells completely free of viral vectors and exotic genes.